Intelligence Platform

Patents

Browse 1,015 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7780963

Anti-ADDL antibodies and uses thereof

Northwestern University · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7777019

Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7777000

Anti-viral activity of cathelicidin peptides

The Regents of the University of California · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763719

Variants of humanized anti-carcinoma MAb CC49

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7732196

Anti-angiogenic methods and compositions

Sangamo Biosciences, Inc. · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7727525

Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics

The Regents of the University of California · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7704962

Small oligonucleotides with anti-tumor activity

The Board of Regents of the University of Texas System · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691567

Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators

The Board of Regents of the University of Texas System · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666989

Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof

Beijing Sunbio Biotech Co. Ltd. · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662860

3D-structure model of SARS coronavirus 3CL protease and anti-SARS drugs

Shanghai Lead Discovery Pharmaceuticals Limited Company · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662607

Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

New Century Pharmaceuticals, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7658923

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing C

The Board of Regents of the University of Texas System · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7635476

Anti-hepatitis a virus antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632814

HYD1 peptides as anti-cancer agents

The Regents of the University of California · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572828

Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569673

Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569542

Anti-microbial targeting chimeric pharmaceutical

The Regents of the University of California · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7556804

Anti-HGF-R antibodies and their use

UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO” · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553936

Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7528274

Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521535

Anti-microbial defensin-related peptides and methods of use

The Board of Regents for Oklahoma State University · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7511124

Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral age

The Board of Regents of the University of Texas System · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7504430

Maleiimide anti-tumor phosphatase inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7498353

Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted